StonvexLoading…
StonvexStonvexStonvexCore line items from NEU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.73B | $2.79B | $2.70B | $2.76B |
Operating Income | $543.73M | $590.04M | $483.05M | $355.14M |
Net Income | $418.75M | $462.41M | $388.86M | $279.54M |
EPS (Diluted) | $44.44 | $48.22 | $40.44 | $27.77 |
Total Assets | $3.49B | $3.13B | $2.31B | $2.41B |
Total Liabilities | $1.71B | $1.67B | $1.23B | $1.64B |
Cash & Equivalents | $77.60M | $77.48M | $111.94M | $68.71M |
Free Cash Flow OCF − CapEx | $491.33M | $462.27M | $528.53M | $52.45M |
Shares Outstanding | 9.40M | 9.52M | 9.59M | 9.70M |